Sensus Healthcare stock down 1.53% with anticipated decrease in earnings and revenue

From Nasdaq: 2024-12-20 18:15:09

Sensus Healthcare, Inc. (SRTS) closed at $7.10, down 1.53% from the prior day, lagging behind the S&P 500. Analysts anticipate earnings of $0.10 per share, a 61.54% decrease year-over-year, with revenue expected to decline by 21.6%. Estimates for the fiscal year project earnings of $0.41 per share and revenue of $38.6 million.

The Zacks Rank system rates Sensus Healthcare, Inc. as a #2 (Buy), with a forward P/E ratio of 17.58, lower than the industry average. The Medical – Instruments industry has a Zacks Industry Rank of 49, in the top 20% of all industries. Investors should monitor these metrics and more on Zacks.com.

Zacks has identified a top semiconductor stock poised for growth in AI, Machine Learning, and IoT markets. With projected global semiconductor manufacturing growth from $452 billion in 2021 to $803 billion by 2028, this stock offers significant potential. Get the latest recommendations from Zacks Investment Research today.



Read more at Nasdaq: Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade